Solid Midfacial Implants: When Fillers Are Not Enough

Abstract

The aging process results in volumetric changes on multiple levels of the face including the skin, soft tissue, and underlying facial skeleton. Malar and mandibular augmentation with facial fillers and alloplastic implants are two treatment options used to achieve the goal of volume enhancement. Noninvasive modalities have become increasingly popular due to the availability of office-based options that require a limited understanding of facial aesthetics, a basic grasp of the mechanisms behind the aging process, and no level of surgical expertise or training. It is important, however, to understand the limitations and appropriate use of each technique, surgical and nonsurgical, either as a sole modality or in conjunction with each other to attain optimal aesthetic results. Although minimally invasive soft-tissue augmentation procedures such as fillers offer midface treatment options, alloplastic implants provide a stable support platform or scaffolding for skeletal and soft-tissue augmentation that fillers alone cannot often provide. A multilevel understanding of facial aesthetics must include the facial skeletal architecture and foundation that it provides for proper soft-tissue draping and contour. Alloplastic implants remain the standard for skeletal augmentation and remain the mainstay when fillers are not sufficient for midface augmentation.

Keywords

facial implant surgery - facial fillers - Malar augmentation - cheek augmentation

• References

• 1 Binder WJ, Kamer FM, Parkes ML. Mentoplasty—a clinical analysis of alloplastic implants. Laryngoscope 1981; 91 (3) 383-391
• 2 Binder WJ. Submalar augmentation. An alternative to face-lift surgery. Arch Otolaryngol Head Neck Surg 1989; 115 (7) 797-801
• 3 American Society of Plastic Surgeons. 2012 Press Release. New ASPS statistics show “chinplants” are fastest growing procedure. Available at: http://www.plasticsurgery.org/News-and-Resources/Press-Release-Archives/2012-Press-Release-Archives/Chin-Surgery-Skyrockets-Among-Women-and-Men.html . Accessed October 1, 2012
• 4 Stallworth CL, Wang TD. Fat grafting of the midface. Facial Plast Surg 2010; 26 (5) 369-375
• 5 Lowe NJ, Grover R. Injectable hyaluronic acid implant for malar and mental enhancement. Dermatol Surg 2006; 32 (7) 881-885 , discussion 885
• 6 Binder WJ, Dhir K, Joseph J. The role of fillers in facial implant surgery. Facial Plast Surg Clin North Am 2013; 21 (2) 201-211
• 7 Shaw Jr RB, Katzel EB, Koltz PF , et al. Aging of the facial skeleton: aesthetic implications and rejuvenation strategies. Plast Reconstr Surg 2011; 127 (1) 374-383
• 8 Kahn DM, Shaw RB. Overview of current thoughts on facial volume and aging. Facial Plast Surg 2010; 26 (5) 350-355
• 9 Binder WJ. Facial rejuvenation and volumization using implants. Facial Plast Surg 2011; 27 (1) 86-97
• 10 Schierle CF, Casas LA. Nonsurgical rejuvenation of the aging face with injectable poly-L-lactic acid for restoration of soft tissue volume. Aesthet Surg J 2011; 31 (1) 95-109
• 11 Hopping SB, Joshi AS, Tanna N, Janjanin S. Volumetric facelift: evaluation of rhytidectomy with alloplastic augmentation. Ann Otol Rhinol Laryngol 2010; 119 (3) 174-180
• 12 Coleman SR. Long-term survival of fat transplants: controlled demonstrations. Aesthetic Plast Surg 1995; 19 (5) 421-425
• 13 Lambros V. Fat contouring in the face and neck. Clin Plast Surg 1992; 19 (2) 401-414
• 14 Kontis TC, Rivkin A. The history of injectable facial fillers. Facial Plast Surg 2009; 25 (2) 67-72
• 15 Kim JJ, Evans GR. Applications of biomaterials in plastic surgery. Clin Plast Surg 2012; 39 (4) 359-376
• 16 Andre P. New trends in face rejuvenation by hyaluronic acid injections. J Cosmet Dermatol 2008; 7 (4) 251-258
• 17 DeJoseph LM. Cannulas for facial filler placement. Facial Plast Surg Clin North Am 2012; 20 (2) 215-220 , vi–vii
• 18 Lazzeri D, Agostini T, Figus M, Nardi M, Pantaloni M, Lazzeri S. Blindness following cosmetic injections of the face. Plast Reconstr Surg 2012; 129 (4) 995-1012
• 19 Cox SE, Adigun CG. Complications of injectable fillers and neurotoxins. Dermatol Ther 2011; 24 (6) 524-536
• 20 Kranendonk S, Obagi S. Autologous fat transfer for periorbital rejuvenation: indications, technique, and complications. Dermatol Surg 2007; 33 (5) 572-578
• 21 Rubin JP, Yaremchuk MJ. Complications and toxicities of implantable biomaterials used in facial reconstructive and aesthetic surgery: a comprehensive review of the literature. Plast Reconstr Surg 1997; 100 (5) 1336-1353
• 22 Karnik J, Baumann L, Bruce S , et al. A double-blind, randomized, multicenter, controlled trial of suspended polymethylmethacrylate microspheres for the correction of atrophic facial acne scars. J Am Acad Dermatol 2014; 71 (1) 77-83
• 23 Lacombe V. Sculptra: a stimulatory filler. Facial Plast Surg 2009; 25 (2) 95-99
• 24 Pontius AT, Chaiet SR, Williams III EF. Midface injectable fillers: have they replaced midface surgery?. Facial Plast Surg Clin North Am 2013; 21 (2) 229-239
• 25 Few J, Cox SE, Paradkar-Mitragotri D, Murphy DKA. A multicenter, single-blind randomized, controlled study of a volumizing hyaluronic acid filler for midface volume deficit: patient-reported outcomes at 2 years. Aesthet Surg J 2015; 35 (5) 589-599